ZA200201959B - Methods related to immunostimulatory nucleic acid-induced interferon. - Google Patents

Info

Publication number

ZA200201959B

ZA200201959B ZA200201959A ZA200201959A ZA200201959B ZA 200201959 B ZA200201959 B ZA 200201959B ZA 200201959 A ZA200201959 A ZA 200201959A ZA 200201959 A ZA200201959 A ZA 200201959A ZA 200201959 B ZA200201959 B ZA 200201959B

Authority

ZA

South Africa

Prior art keywords

odn

seq

nucleic acid

seqid

ifn

Prior art date

1999-09-27

Links

• Espacenet
• Global Dossier
• Discuss

• 108020004707 nucleic acids Proteins 0.000 title claims description 368
• 102000039446 nucleic acids Human genes 0.000 title claims description 368
• 150000007523 nucleic acids Chemical class 0.000 title claims description 325
• 230000003308 immunostimulating effect Effects 0.000 title claims description 194
• 238000000034 method Methods 0.000 title claims description 152
• 102000014150 Interferons Human genes 0.000 title description 30
• 108010050904 Interferons Proteins 0.000 title description 30
• 229940079322 interferon Drugs 0.000 title description 27
• 210000004027 cell Anatomy 0.000 claims description 186
• 210000004544 dc2 Anatomy 0.000 claims description 114
• 238000011282 treatment Methods 0.000 claims description 96
• 125000003729 nucleotide group Chemical group 0.000 claims description 84
• 230000000694 effects Effects 0.000 claims description 69
• 231100000682 maximum tolerated dose Toxicity 0.000 claims description 64
• 210000001744 T-lymphocyte Anatomy 0.000 claims description 63
• 239000002773 nucleotide Substances 0.000 claims description 63
• -1 CpG nucleic acid Chemical class 0.000 claims description 60
• 108010002386 Interleukin-3 Proteins 0.000 claims description 56
• 102000000646 Interleukin-3 Human genes 0.000 claims description 56
• 229940076264 interleukin-3 Drugs 0.000 claims description 56
• OGIAAULPRXAQEV-UHFFFAOYSA-N odn 2216 Chemical compound O=C1NC(=O)C(C)=CN1C1OC(COP(O)(=O)OC2C(OC(C2)N2C3=NC=NC(N)=C3N=C2)COP(O)(=O)OC2C(OC(C2)N2C3=C(C(NC(N)=N3)=O)N=C2)COP(O)(=O)OC2C(OC(C2)N2C(N=C(N)C=C2)=O)COP(O)(=O)OC2C(OC(C2)N2C3=NC=NC(N)=C3N=C2)COP(O)(=O)OC2C(OC(C2)N2C3=C(C(NC(N)=N3)=O)N=C2)COP(O)(=O)OC2C(OC(C2)N2C3=C(C(NC(N)=N3)=O)N=C2)COP(O)(=O)OC2C(OC(C2)N2C3=C(C(NC(N)=N3)=O)N=C2)COP(O)(=O)OC2C(OC(C2)N2C3=C(C(NC(N)=N3)=O)N=C2)COP(O)(=O)OC2C(OC(C2)N2C3=C(C(NC(N)=N3)=O)N=C2)COP(O)(O)=O)C(OP(O)(=O)OCC2C(CC(O2)N2C(N=C(N)C=C2)=O)OP(O)(=O)OCC2C(CC(O2)N2C3=C(C(NC(N)=N3)=O)N=C2)OP(O)(=O)OCC2C(CC(O2)N2C(NC(=O)C(C)=C2)=O)OP(O)(=O)OCC2C(CC(O2)N2C(N=C(N)C=C2)=O)OP(O)(=O)OCC2C(CC(O2)N2C3=C(C(NC(N)=N3)=O)N=C2)OP(O)(=O)OCC2C(CC(O2)N2C3=C(C(NC(N)=N3)=O)N=C2)OP(O)(=O)OCC2C(CC(O2)N2C3=C(C(NC(N)=N3)=O)N=C2)OP(O)(=O)OCC2C(CC(O2)N2C3=C(C(NC(N)=N3)=O)N=C2)OP(O)(=O)OCC2C(CC(O2)N2C3=C(C(NC(N)=N3)=O)N=C2)OP(O)(=O)OCC2C(CC(O2)N2C3=C(C(NC(N)=N3)=O)N=C2)O)C1 OGIAAULPRXAQEV-UHFFFAOYSA-N 0.000 claims description 53
• 241000700605 Viruses Species 0.000 claims description 51
• 239000003814 drug Substances 0.000 claims description 47
• 238000000338 in vitro Methods 0.000 claims description 44
• 238000004519 manufacturing process Methods 0.000 claims description 43
• 239000000203 mixture Substances 0.000 claims description 43
• 239000008194 pharmaceutical composition Substances 0.000 claims description 41
• RYYWUUFWQRZTIU-UHFFFAOYSA-K thiophosphate Chemical compound [O-]P([O-])([O-])=S RYYWUUFWQRZTIU-UHFFFAOYSA-K 0.000 claims description 41
• 230000001939 inductive effect Effects 0.000 claims description 40
• 108090000765 processed proteins & peptides Proteins 0.000 claims description 39
• 102100039620 Granulocyte-macrophage colony-stimulating factor Human genes 0.000 claims description 37
• 239000000427 antigen Substances 0.000 claims description 35
• 102000036639 antigens Human genes 0.000 claims description 35
• 108091007433 antigens Proteins 0.000 claims description 35
• 230000009385 viral infection Effects 0.000 claims description 29
• 208000036142 Viral infection Diseases 0.000 claims description 28
• 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 28
• 150000004713 phosphodiesters Chemical class 0.000 claims description 27
• 230000002062 proliferating effect Effects 0.000 claims description 25
• 208000035475 disorder Diseases 0.000 claims description 23
• 230000001965 increasing effect Effects 0.000 claims description 21
• 238000009472 formulation Methods 0.000 claims description 18
• 239000003102 growth factor Substances 0.000 claims description 18
• 238000002347 injection Methods 0.000 claims description 18
• 239000007924 injection Substances 0.000 claims description 18
• 230000028327 secretion Effects 0.000 claims description 18
• 108010014726 Interferon Type I Proteins 0.000 claims description 17
• 102000002227 Interferon Type I Human genes 0.000 claims description 17
• 230000004083 survival effect Effects 0.000 claims description 17
• 210000004443 dendritic cell Anatomy 0.000 claims description 16
• 230000002829 reductive effect Effects 0.000 claims description 16
• 101710163270 Nuclease Proteins 0.000 claims description 15
• NAGJZTKCGNOGPW-UHFFFAOYSA-K dioxido-sulfanylidene-sulfido-$l^{5}-phosphane Chemical compound [O-]P([O-])([S-])=S NAGJZTKCGNOGPW-UHFFFAOYSA-K 0.000 claims description 15
• YACKEPLHDIMKIO-UHFFFAOYSA-N methylphosphonic acid Chemical compound CP(O)(O)=O YACKEPLHDIMKIO-UHFFFAOYSA-N 0.000 claims description 15
• 238000002360 preparation method Methods 0.000 claims description 15
• 206010059313 Anogenital warts Diseases 0.000 claims description 14
• 108010065805 Interleukin-12 Proteins 0.000 claims description 14
• 102000013462 Interleukin-12 Human genes 0.000 claims description 14
• 201000009030 Carcinoma Diseases 0.000 claims description 13
• 241001631646 Papillomaviridae Species 0.000 claims description 13
• 230000004936 stimulating effect Effects 0.000 claims description 13
• 210000001519 tissue Anatomy 0.000 claims description 13
• 208000030507 AIDS Diseases 0.000 claims description 12
• 206010009944 Colon cancer Diseases 0.000 claims description 12
• 241000701022 Cytomegalovirus Species 0.000 claims description 12
• 208000007766 Kaposi sarcoma Diseases 0.000 claims description 12
• 208000034578 Multiple myelomas Diseases 0.000 claims description 12
• 206010035226 Plasma cell myeloma Diseases 0.000 claims description 12
• 208000000389 T-cell leukemia Diseases 0.000 claims description 12
• 208000028530 T-cell lymphoblastic leukemia/lymphoma Diseases 0.000 claims description 12
• 201000001441 melanoma Diseases 0.000 claims description 12
• 239000002243 precursor Substances 0.000 claims description 12
• 208000032791 BCR-ABL1 positive chronic myelogenous leukemia Diseases 0.000 claims description 11
• 206010008263 Cervical dysplasia Diseases 0.000 claims description 11
• 208000005176 Hepatitis C Diseases 0.000 claims description 11
• 241000725303 Human immunodeficiency virus Species 0.000 claims description 11
• 206010060862 Prostate cancer Diseases 0.000 claims description 11
• 208000006265 Renal cell carcinoma Diseases 0.000 claims description 11
• 210000003443 bladder cell Anatomy 0.000 claims description 11
• 208000035250 cutaneous malignant susceptibility to 1 melanoma Diseases 0.000 claims description 11
• 201000009277 hairy cell leukemia Diseases 0.000 claims description 11
• 208000002672 hepatitis B Diseases 0.000 claims description 11
• 208000010833 Chronic myeloid leukaemia Diseases 0.000 claims description 10
• 241000701044 Human gammaherpesvirus 4 Species 0.000 claims description 10
• XQFRJNBWHJMXHO-RRKCRQDMSA-N IDUR Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(I)=C1 XQFRJNBWHJMXHO-RRKCRQDMSA-N 0.000 claims description 10
• 208000033761 Myelogenous Chronic BCR-ABL Positive Leukemia Diseases 0.000 claims description 10
• 210000004204 blood vessel Anatomy 0.000 claims description 10
• 239000002253 acid Substances 0.000 claims description 9
• 238000012258 culturing Methods 0.000 claims description 9
• 201000003444 follicular lymphoma Diseases 0.000 claims description 9
• 230000019734 interleukin-12 production Effects 0.000 claims description 9
• 201000001514 prostate carcinoma Diseases 0.000 claims description 9
• 206010041823 squamous cell carcinoma Diseases 0.000 claims description 9
• 230000009885 systemic effect Effects 0.000 claims description 7
• 230000002708 enhancing effect Effects 0.000 claims description 6
• 210000002434 celiac artery Anatomy 0.000 claims description 5
• 239000003937 drug carrier Substances 0.000 claims description 5
• 210000002767 hepatic artery Anatomy 0.000 claims description 5
• 210000003240 portal vein Anatomy 0.000 claims description 5
• 230000008093 supporting effect Effects 0.000 claims description 5
• 230000003247 decreasing effect Effects 0.000 claims description 4
• 210000002563 splenic artery Anatomy 0.000 claims description 4
• 206010012735 Diarrhoea Diseases 0.000 claims description 3
• 206010019233 Headaches Diseases 0.000 claims description 3
• 208000000112 Myalgia Diseases 0.000 claims description 3
• 206010028813 Nausea Diseases 0.000 claims description 3
• 206010037660 Pyrexia Diseases 0.000 claims description 3
• 206010047700 Vomiting Diseases 0.000 claims description 3
• 208000022531 anorexia Diseases 0.000 claims description 3
• 206010061428 decreased appetite Diseases 0.000 claims description 3
• 206010016256 fatigue Diseases 0.000 claims description 3
• 230000012010 growth Effects 0.000 claims description 3
• 231100000869 headache Toxicity 0.000 claims description 3
• 230000008693 nausea Effects 0.000 claims description 3
• 208000011580 syndromic disease Diseases 0.000 claims description 3
• 230000008673 vomiting Effects 0.000 claims description 3
• 230000002401 inhibitory effect Effects 0.000 claims description 2
• 208000032839 leukemia Diseases 0.000 claims description 2
• 239000013589 supplement Substances 0.000 claims description 2
• 108010017213 Granulocyte-Macrophage Colony-Stimulating Factor Proteins 0.000 claims 6
• 238000011260 co-administration Methods 0.000 claims 4
• 206010061598 Immunodeficiency Diseases 0.000 claims 1
• 208000029462 Immunodeficiency disease Diseases 0.000 claims 1
• 230000007813 immunodeficiency Effects 0.000 claims 1
• 229940046166 oligodeoxynucleotide Drugs 0.000 description 265
• 229940046168 CpG oligodeoxynucleotide Drugs 0.000 description 167
• 108091034117 Oligonucleotide Proteins 0.000 description 84
• CTMZLDSMFCVUNX-VMIOUTBZSA-N cytidylyl-(3'->5')-guanosine Chemical class O=C1N=C(N)C=CN1[C@H]1[C@H](O)[C@H](OP(O)(=O)OC[C@@H]2[C@H]([C@@H](O)[C@@H](O2)N2C3=C(C(N=C(N)N3)=O)N=C2)O)[C@@H](CO)O1 CTMZLDSMFCVUNX-VMIOUTBZSA-N 0.000 description 76
• 210000003819 peripheral blood mononuclear cell Anatomy 0.000 description 67
• 101000959820 Homo sapiens Interferon alpha-1/13 Proteins 0.000 description 62
• 102100040019 Interferon alpha-1/13 Human genes 0.000 description 62
• KDWFDOFTPHDNJL-TUBOTVQJSA-N odn-2006 Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](COP(O)(=O)O[C@@H]2[C@H](O[C@H](C2)N2C(NC(=O)C(C)=C2)=O)COP(O)(=O)O[C@H]2[C@H]([C@@H](O[C@@H]2COP(O)(=S)O[C@H]2[C@H]([C@@H](O[C@@H]2COP(O)(=O)O[C@@H]2[C@H](O[C@H](C2)N2C(NC(=O)C(C)=C2)=O)COP(O)(=O)O[C@@H]2[C@H](O[C@H](C2)N2C(NC(=O)C(C)=C2)=O)COP(O)(=O)O[C@@H]2[C@H](O[C@H](C2)N2C(NC(=O)C(C)=C2)=O)COP(O)(=O)O[C@@H]2[C@H](O[C@H](C2)N2C(NC(=O)C(C)=C2)=O)COP(O)(=O)O[C@H]2[C@H]([C@@H](O[C@@H]2COP(O)(=O)O[C@@H]2[C@H](O[C@H](C2)N2C(NC(=O)C(C)=C2)=O)COP(O)(=O)O[C@H]2[C@H]([C@@H](O[C@@H]2COP(O)(=S)O[C@H]2[C@H]([C@@H](O[C@@H]2COP(O)(=O)OC[C@@H]2[C@H](C[C@@H](O2)N2C(NC(=O)C(C)=C2)=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](O)[C@@H](O2)N2C3=C(C(NC(N)=N3)=O)N=C2)OP(O)(=O)OC[C@@H]2[C@H](C[C@@H](O2)N2C(NC(=O)C(C)=C2)=O)OP(O)(=O)OC[C@@H]2[C@H](C[C@@H](O2)N2C(NC(=O)C(C)=C2)=O)OP(O)(=O)OC[C@@H]2[C@H](C[C@@H](O2)N2C(NC(=O)C(C)=C2)=O)OP(O)(=O)OC[C@@H]2[C@H](C[C@@H](O2)N2C(NC(=O)C(C)=C2)=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](O)[C@@H](O2)N2C3=C(C(NC(N)=N3)=O)N=C2)OP(S)(=O)OC[C@@H]2[C@H]([C@@H](O)[C@@H](O2)N2C(N=C(N)C=C2)=O)OP(O)(=O)OC[C@@H]2[C@H](C[C@@H](O2)N2C(NC(=O)C(C)=C2)=O)OP(O)(=O)OC[C@@H]2[C@H](C[C@@H](O2)N2C(NC(=O)C(C)=C2)=O)O)N2C3=C(C(NC(N)=N3)=O)N=C2)O)N2C(N=C(N)C=C2)=O)O)N2C3=C(C(NC(N)=N3)=O)N=C2)O)N2C3=C(C(NC(N)=N3)=O)N=C2)O)N2C(N=C(N)C=C2)=O)O)[C@@H](O)C1 KDWFDOFTPHDNJL-TUBOTVQJSA-N 0.000 description 42
• JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 31
• NUHSROFQTUXZQQ-UHFFFAOYSA-N isopentenyl diphosphate Chemical compound CC(=C)CCO[P@](O)(=O)OP(O)(O)=O NUHSROFQTUXZQQ-UHFFFAOYSA-N 0.000 description 31
• 230000004044 response Effects 0.000 description 31
• 150000001875 compounds Chemical class 0.000 description 30
• 210000000822 natural killer cell Anatomy 0.000 description 25
• 238000002474 experimental method Methods 0.000 description 20
• 230000004913 activation Effects 0.000 description 19
• 239000003795 chemical substances by application Substances 0.000 description 19
• 238000001943 fluorescence-activated cell sorting Methods 0.000 description 18
• 239000000411 inducer Substances 0.000 description 18
• 239000002609 medium Substances 0.000 description 18
• 101000914484 Homo sapiens T-lymphocyte activation antigen CD80 Proteins 0.000 description 17
• 102100027222 T-lymphocyte activation antigen CD80 Human genes 0.000 description 17
• 238000002965 ELISA Methods 0.000 description 16
• 210000003719 b-lymphocyte Anatomy 0.000 description 16
• 230000004048 modification Effects 0.000 description 16
• 238000012986 modification Methods 0.000 description 16
• 238000000684 flow cytometry Methods 0.000 description 15
• 108090000623 proteins and genes Proteins 0.000 description 15
• 102000006354 HLA-DR Antigens Human genes 0.000 description 14
• 108010058597 HLA-DR Antigens Proteins 0.000 description 14
• 102100036011 T-cell surface glycoprotein CD4 Human genes 0.000 description 14
• 150000003839 salts Chemical class 0.000 description 14
• 230000001225 therapeutic effect Effects 0.000 description 14
• 102000043131 MHC class II family Human genes 0.000 description 13
• 108091054438 MHC class II family Proteins 0.000 description 13
• 108060008682 Tumor Necrosis Factor Proteins 0.000 description 13
• 102100040247 Tumor necrosis factor Human genes 0.000 description 13
• 238000004458 analytical method Methods 0.000 description 13
• 206010022000 influenza Diseases 0.000 description 13
• 102000004169 proteins and genes Human genes 0.000 description 13
• 230000000638 stimulation Effects 0.000 description 13
• 241001430294 unidentified retrovirus Species 0.000 description 13
• 238000001727 in vivo Methods 0.000 description 12
• 230000003834 intracellular effect Effects 0.000 description 12
• 206010028980 Neoplasm Diseases 0.000 description 11
• 238000010186 staining Methods 0.000 description 11
• 229920000642 polymer Polymers 0.000 description 10
• 239000006228 supernatant Substances 0.000 description 10
• 102000004127 Cytokines Human genes 0.000 description 9
• 108090000695 Cytokines Proteins 0.000 description 9
• 108020004414 DNA Proteins 0.000 description 9
• 238000011534 incubation Methods 0.000 description 9
• 230000006698 induction Effects 0.000 description 9
• 108090001007 Interleukin-8 Proteins 0.000 description 8
• 241000251539 Vertebrata <Metazoa> Species 0.000 description 8
• 230000000875 corresponding effect Effects 0.000 description 8
• OPTASPLRGRRNAP-UHFFFAOYSA-N cytosine Chemical compound NC=1C=CNC(=O)N=1 OPTASPLRGRRNAP-UHFFFAOYSA-N 0.000 description 8
• UYTPUPDQBNUYGX-UHFFFAOYSA-N guanine Chemical compound O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 description 8
• 208000015181 infectious disease Diseases 0.000 description 8
• 239000000725 suspension Substances 0.000 description 8
• RWQNBRDOKXIBIV-UHFFFAOYSA-N thymine Chemical class CC1=CNC(=O)NC1=O RWQNBRDOKXIBIV-UHFFFAOYSA-N 0.000 description 8
• 241000709661 Enterovirus Species 0.000 description 7
• 229910019142 PO4 Inorganic materials 0.000 description 7
• KQNZDYYTLMIZCT-KQPMLPITSA-N brefeldin A Chemical compound O[C@@H]1\C=C\C(=O)O[C@@H](C)CCC\C=C\[C@@H]2C[C@H](O)C[C@H]21 KQNZDYYTLMIZCT-KQPMLPITSA-N 0.000 description 7
• JUMGSHROWPPKFX-UHFFFAOYSA-N brefeldin-A Natural products CC1CCCC=CC2(C)CC(O)CC2(C)C(O)C=CC(=O)O1 JUMGSHROWPPKFX-UHFFFAOYSA-N 0.000 description 7
• 239000000872 buffer Substances 0.000 description 7
• 239000002775 capsule Substances 0.000 description 7
• 229940079593 drug Drugs 0.000 description 7
• 239000002158 endotoxin Substances 0.000 description 7
• 239000007788 liquid Substances 0.000 description 7
• 210000001616 monocyte Anatomy 0.000 description 7
• 210000005134 plasmacytoid dendritic cell Anatomy 0.000 description 7
• 239000000047 product Substances 0.000 description 7
• 230000035755 proliferation Effects 0.000 description 7
• 235000000346 sugar Nutrition 0.000 description 7
• 239000003826 tablet Substances 0.000 description 7
• 241000712461 unidentified influenza virus Species 0.000 description 7
• 241000699666 Mus <mouse, genus> Species 0.000 description 6
• 108091081548 Palindromic sequence Proteins 0.000 description 6
• 108010004729 Phycoerythrin Proteins 0.000 description 6
• 239000012190 activator Substances 0.000 description 6
• 238000004113 cell culture Methods 0.000 description 6
• 210000000265 leukocyte Anatomy 0.000 description 6
• 230000001404 mediated effect Effects 0.000 description 6
• 108020004999 messenger RNA Proteins 0.000 description 6
• 230000003472 neutralizing effect Effects 0.000 description 6
• 239000010452 phosphate Substances 0.000 description 6
• 239000007787 solid Substances 0.000 description 6
• 239000000243 solution Substances 0.000 description 6
• 238000012360 testing method Methods 0.000 description 6
• 101150013553 CD40 gene Proteins 0.000 description 5
• 108091029430 CpG site Proteins 0.000 description 5
• 102100025137 Early activation antigen CD69 Human genes 0.000 description 5
• 108010010803 Gelatin Proteins 0.000 description 5
• 101000934374 Homo sapiens Early activation antigen CD69 Proteins 0.000 description 5
• 108010010995 MART-1 Antigen Proteins 0.000 description 5
• 241000712079 Measles morbillivirus Species 0.000 description 5
• 102000001708 Protein Isoforms Human genes 0.000 description 5
• 108010029485 Protein Isoforms Proteins 0.000 description 5
• 229920002472 Starch Polymers 0.000 description 5
• 102100040245 Tumor necrosis factor receptor superfamily member 5 Human genes 0.000 description 5
• 239000011324 bead Substances 0.000 description 5
• 239000000969 carrier Substances 0.000 description 5
• 230000015556 catabolic process Effects 0.000 description 5
• 230000000139 costimulatory effect Effects 0.000 description 5
• 238000006731 degradation reaction Methods 0.000 description 5
• 201000010099 disease Diseases 0.000 description 5
• 229920000159 gelatin Polymers 0.000 description 5
• 239000008273 gelatin Substances 0.000 description 5
• 235000019322 gelatine Nutrition 0.000 description 5
• 235000011852 gelatine desserts Nutrition 0.000 description 5
• 210000002865 immune cell Anatomy 0.000 description 5
• 210000000987 immune system Anatomy 0.000 description 5
• 238000001802 infusion Methods 0.000 description 5
• 230000005764 inhibitory process Effects 0.000 description 5
• 239000011159 matrix material Substances 0.000 description 5
• 239000000546 pharmaceutical excipient Substances 0.000 description 5
• NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 5
• 230000003389 potentiating effect Effects 0.000 description 5
• 241000894007 species Species 0.000 description 5
• 229940124597 therapeutic agent Drugs 0.000 description 5
• 239000003981 vehicle Substances 0.000 description 5
• GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 4
• 229930024421 Adenine Natural products 0.000 description 4
• 241000271566 Aves Species 0.000 description 4
• 102100024222 B-lymphocyte antigen CD19 Human genes 0.000 description 4
• 241000283690 Bos taurus Species 0.000 description 4
• 108010029697 CD40 Ligand Proteins 0.000 description 4
• 102100032937 CD40 ligand Human genes 0.000 description 4
• 208000000907 Condylomata Acuminata Diseases 0.000 description 4
• 241000712471 Dhori virus Species 0.000 description 4
• 241000282412 Homo Species 0.000 description 4
• 101000980825 Homo sapiens B-lymphocyte antigen CD19 Proteins 0.000 description 4
• 102000014158 Interleukin-12 Subunit p40 Human genes 0.000 description 4
• 108010011429 Interleukin-12 Subunit p40 Proteins 0.000 description 4
• 108010002350 Interleukin-2 Proteins 0.000 description 4
• 102000000588 Interleukin-2 Human genes 0.000 description 4
• 241001465754 Metazoa Species 0.000 description 4
• KHGNFPUMBJSZSM-UHFFFAOYSA-N Perforine Natural products COC1=C2CCC(O)C(CCC(C)(C)O)(OC)C2=NC2=C1C=CO2 KHGNFPUMBJSZSM-UHFFFAOYSA-N 0.000 description 4
• 241001505332 Polyomavirus sp. Species 0.000 description 4
• 241000702670 Rotavirus Species 0.000 description 4
• 241000714474 Rous sarcoma virus Species 0.000 description 4
• 229960000643 adenine Drugs 0.000 description 4
• 238000003556 assay Methods 0.000 description 4
• 239000011230 binding agent Substances 0.000 description 4
• 230000015572 biosynthetic process Effects 0.000 description 4
• 230000037396 body weight Effects 0.000 description 4
• 230000004700 cellular uptake Effects 0.000 description 4
• 238000012512 characterization method Methods 0.000 description 4
• HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
• 229940104302 cytosine Drugs 0.000 description 4
• 210000001151 cytotoxic T lymphocyte Anatomy 0.000 description 4
• 230000001419 dependent effect Effects 0.000 description 4
• 238000001514 detection method Methods 0.000 description 4
• 239000008298 dragée Substances 0.000 description 4
• MHMNJMPURVTYEJ-UHFFFAOYSA-N fluorescein-5-isothiocyanate Chemical compound O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 MHMNJMPURVTYEJ-UHFFFAOYSA-N 0.000 description 4
• 239000000499 gel Substances 0.000 description 4
• 230000002458 infectious effect Effects 0.000 description 4
• 238000002955 isolation Methods 0.000 description 4
• 230000003902 lesion Effects 0.000 description 4
• 239000002502 liposome Substances 0.000 description 4
• 230000002101 lytic effect Effects 0.000 description 4
• 239000003550 marker Substances 0.000 description 4
• 229930192851 perforin Natural products 0.000 description 4
• 239000000825 pharmaceutical preparation Substances 0.000 description 4
• 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 4
• 229920000036 polyvinylpyrrolidone Polymers 0.000 description 4
• 239000001267 polyvinylpyrrolidone Substances 0.000 description 4
• 239000000843 powder Substances 0.000 description 4
• 230000037452 priming Effects 0.000 description 4
• 102000004196 processed proteins & peptides Human genes 0.000 description 4
• 150000003230 pyrimidines Chemical class 0.000 description 4
• 102000005962 receptors Human genes 0.000 description 4
• 108020003175 receptors Proteins 0.000 description 4
• 239000003381 stabilizer Substances 0.000 description 4
• 235000019698 starch Nutrition 0.000 description 4
• 150000008163 sugars Chemical class 0.000 description 4
• 238000003786 synthesis reaction Methods 0.000 description 4
• 229940113082 thymine Drugs 0.000 description 4
• 241000701161 unidentified adenovirus Species 0.000 description 4
• 230000003612 virological effect Effects 0.000 description 4
• JRYMOPZHXMVHTA-DAGMQNCNSA-N 2-amino-7-[(2r,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1h-pyrrolo[2,3-d]pyrimidin-4-one Chemical compound C1=CC=2C(=O)NC(N)=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O JRYMOPZHXMVHTA-DAGMQNCNSA-N 0.000 description 3
• QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
• 241000251468 Actinopterygii Species 0.000 description 3
• UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
• FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 3
• FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 3
• 241000450599 DNA viruses Species 0.000 description 3
• 108010042407 Endonucleases Proteins 0.000 description 3
• 241000991587 Enterovirus C Species 0.000 description 3
• 241000283073 Equus caballus Species 0.000 description 3
• PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
• 101000946889 Homo sapiens Monocyte differentiation antigen CD14 Proteins 0.000 description 3
• 101000581981 Homo sapiens Neural cell adhesion molecule 1 Proteins 0.000 description 3
• 102000008070 Interferon-gamma Human genes 0.000 description 3
• 108010074328 Interferon-gamma Proteins 0.000 description 3
• GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 3
• 102100028389 Melanoma antigen recognized by T-cells 1 Human genes 0.000 description 3
• 102100037510 Metallothionein-1E Human genes 0.000 description 3
• 102100035877 Monocyte differentiation antigen CD14 Human genes 0.000 description 3
• 241000711386 Mumps virus Species 0.000 description 3
• 241000711408 Murine respirovirus Species 0.000 description 3
• 102100027347 Neural cell adhesion molecule 1 Human genes 0.000 description 3
• 241000712464 Orthomyxoviridae Species 0.000 description 3
• 241000150218 Orthonairovirus Species 0.000 description 3
• 241000711504 Paramyxoviridae Species 0.000 description 3
• 208000002606 Paramyxoviridae Infections Diseases 0.000 description 3
• 241000713137 Phlebovirus Species 0.000 description 3
• 241000725643 Respiratory syncytial virus Species 0.000 description 3
• 241000710799 Rubella virus Species 0.000 description 3
• FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 3
• 238000000692 Student's t-test Methods 0.000 description 3
• 230000006052 T cell proliferation Effects 0.000 description 3
• 241000711975 Vesicular stomatitis virus Species 0.000 description 3
• HMNZFMSWFCAGGW-XPWSMXQVSA-N [3-[hydroxy(2-hydroxyethoxy)phosphoryl]oxy-2-[(e)-octadec-9-enoyl]oxypropyl] (e)-octadec-9-enoate Chemical compound CCCCCCCC\C=C\CCCCCCCC(=O)OCC(COP(O)(=O)OCCO)OC(=O)CCCCCCC\C=C\CCCCCCCC HMNZFMSWFCAGGW-XPWSMXQVSA-N 0.000 description 3
• 150000007513 acids Chemical class 0.000 description 3
• 239000000443 aerosol Substances 0.000 description 3
• 230000000692 anti-sense effect Effects 0.000 description 3
• 210000000612 antigen-presenting cell Anatomy 0.000 description 3
• 230000027455 binding Effects 0.000 description 3
• 201000011510 cancer Diseases 0.000 description 3
• 239000001768 carboxy methyl cellulose Substances 0.000 description 3
• KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
• 230000007012 clinical effect Effects 0.000 description 3
• 238000000576 coating method Methods 0.000 description 3
• 230000009089 cytolysis Effects 0.000 description 3
• 231100000371 dose-limiting toxicity Toxicity 0.000 description 3
• 239000000839 emulsion Substances 0.000 description 3
• 102000013165 exonuclease Human genes 0.000 description 3
• 210000002950 fibroblast Anatomy 0.000 description 3
• 239000000945 filler Substances 0.000 description 3
• 235000019688 fish Nutrition 0.000 description 3
• 230000006870 function Effects 0.000 description 3
• 230000028993 immune response Effects 0.000 description 3
• 230000006872 improvement Effects 0.000 description 3
• 239000004615 ingredient Substances 0.000 description 3
• 230000003993 interaction Effects 0.000 description 3
• 229940047124 interferons Drugs 0.000 description 3
• 238000010212 intracellular staining Methods 0.000 description 3
• 239000008101 lactose Substances 0.000 description 3
• 150000002632 lipids Chemical class 0.000 description 3
• 210000004698 lymphocyte Anatomy 0.000 description 3
• 238000001840 matrix-assisted laser desorption--ionisation time-of-flight mass spectrometry Methods 0.000 description 3
• 230000035800 maturation Effects 0.000 description 3
• 239000004005 microsphere Substances 0.000 description 3
• 210000000056 organ Anatomy 0.000 description 3
• 210000005259 peripheral blood Anatomy 0.000 description 3
• 239000011886 peripheral blood Substances 0.000 description 3
• 230000008823 permeabilization Effects 0.000 description 3
• 125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 description 3
• 229920001223 polyethylene glycol Polymers 0.000 description 3
• 239000003755 preservative agent Substances 0.000 description 3
• 150000003212 purines Chemical class 0.000 description 3
• 239000011780 sodium chloride Substances 0.000 description 3
• 239000000600 sorbitol Substances 0.000 description 3
• 239000000126 substance Substances 0.000 description 3
• 238000006467 substitution reaction Methods 0.000 description 3
• 239000000829 suppository Substances 0.000 description 3
• 238000002560 therapeutic procedure Methods 0.000 description 3
• 231100000419 toxicity Toxicity 0.000 description 3
• 230000001988 toxicity Effects 0.000 description 3
• 241001529453 unidentified herpesvirus Species 0.000 description 3
• 230000035899 viability Effects 0.000 description 3
• 230000003442 weekly effect Effects 0.000 description 3
• 241000701242 Adenoviridae Species 0.000 description 2
• 241000701386 African swine fever virus Species 0.000 description 2
• 241000712892 Arenaviridae Species 0.000 description 2
• 241000711404 Avian avulavirus 1 Species 0.000 description 2
• 241000714230 Avian leukemia virus Species 0.000 description 2
• 241000713838 Avian myeloblastosis virus Species 0.000 description 2
• 230000003844 B-cell-activation Effects 0.000 description 2
• 241000894006 Bacteria Species 0.000 description 2
• 108020000946 Bacterial DNA Proteins 0.000 description 2
• 241001118702 Border disease virus Species 0.000 description 2
• 241001227615 Bovine foamy virus Species 0.000 description 2
• 241000714266 Bovine leukemia virus Species 0.000 description 2
• 241000711895 Bovine orthopneumovirus Species 0.000 description 2
• 241000710780 Bovine viral diarrhea virus 1 Species 0.000 description 2
• VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
• 208000008889 California Encephalitis Diseases 0.000 description 2
• CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
• 241000282693 Cercopithecidae Species 0.000 description 2
• 241001502567 Chikungunya virus Species 0.000 description 2
• 241000710777 Classical swine fever virus Species 0.000 description 2
• PHEDXBVPIONUQT-UHFFFAOYSA-N Cocarcinogen A1 Natural products CCCCCCCCCCCCCC(=O)OC1C(C)C2(O)C3C=C(C)C(=O)C3(O)CC(CO)=CC2C2C1(OC(C)=O)C2(C)C PHEDXBVPIONUQT-UHFFFAOYSA-N 0.000 description 2
• 241000150230 Crimean-Congo hemorrhagic fever orthonairovirus Species 0.000 description 2
• HMFHBZSHGGEWLO-SOOFDHNKSA-N D-ribofuranose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H]1O HMFHBZSHGGEWLO-SOOFDHNKSA-N 0.000 description 2
• 241000725619 Dengue virus Species 0.000 description 2
• 241000255925 Diptera Species 0.000 description 2
• 208000000655 Distemper Diseases 0.000 description 2
• 238000008157 ELISA kit Methods 0.000 description 2
• 241001115402 Ebolavirus Species 0.000 description 2
• 206010014584 Encephalitis california Diseases 0.000 description 2
• 102100031780 Endonuclease Human genes 0.000 description 2
• 102000004533 Endonucleases Human genes 0.000 description 2
• 206010066919 Epidemic polyarthritis Diseases 0.000 description 2
• 241000713730 Equine infectious anemia virus Species 0.000 description 2
• 241000588724 Escherichia coli Species 0.000 description 2
• 108060002716 Exonuclease Proteins 0.000 description 2
• 241000713800 Feline immunodeficiency virus Species 0.000 description 2
• 241000714165 Feline leukemia virus Species 0.000 description 2
• 241000710198 Foot-and-mouth disease virus Species 0.000 description 2
• 241000713813 Gibbon ape leukemia virus Species 0.000 description 2
• 241000711549 Hepacivirus C Species 0.000 description 2
• 241000700721 Hepatitis B virus Species 0.000 description 2
• 241000709721 Hepatovirus A Species 0.000 description 2
• 208000009889 Herpes Simplex Diseases 0.000 description 2
• 241000700586 Herpesviridae Species 0.000 description 2
• 101000917858 Homo sapiens Low affinity immunoglobulin gamma Fc region receptor III-A Proteins 0.000 description 2
• 101000917839 Homo sapiens Low affinity immunoglobulin gamma Fc region receptor III-B Proteins 0.000 description 2
• 241000714259 Human T-lymphotropic virus 2 Species 0.000 description 2
• 241000713673 Human foamy virus Species 0.000 description 2
• 241000713772 Human immunodeficiency virus 1 Species 0.000 description 2
• 241000726041 Human respirovirus 1 Species 0.000 description 2
• 241000714192 Human spumaretrovirus Species 0.000 description 2
• 241000711450 Infectious bronchitis virus Species 0.000 description 2
• 241000712431 Influenza A virus Species 0.000 description 2
• 102100022297 Integrin alpha-X Human genes 0.000 description 2
• 108010047761 Interferon-alpha Proteins 0.000 description 2
• 102000006992 Interferon-alpha Human genes 0.000 description 2
• 108090001005 Interleukin-6 Proteins 0.000 description 2
• 102000004889 Interleukin-6 Human genes 0.000 description 2
• 241000701377 Iridoviridae Species 0.000 description 2
• 241000710842 Japanese encephalitis virus Species 0.000 description 2
• 241000710912 Kunjin virus Species 0.000 description 2
• 201000009908 La Crosse encephalitis Diseases 0.000 description 2
• 206010023849 Laryngeal papilloma Diseases 0.000 description 2
• 241000713666 Lentivirus Species 0.000 description 2
• 102100029185 Low affinity immunoglobulin gamma Fc region receptor III-B Human genes 0.000 description 2
• 102000016200 MART-1 Antigen Human genes 0.000 description 2
• 241000713821 Mason-Pfizer monkey virus Species 0.000 description 2
• 241000713862 Moloney murine sarcoma virus Species 0.000 description 2
• 241000712045 Morbillivirus Species 0.000 description 2
• 241000714177 Murine leukemia virus Species 0.000 description 2
• 241000711941 Murine orthopneumovirus Species 0.000 description 2
• 241000710908 Murray Valley encephalitis virus Species 0.000 description 2
• 230000006051 NK cell activation Effects 0.000 description 2
• 241001457453 Nairobi sheep disease virus Species 0.000 description 2
• 241000710944 O'nyong-nyong virus Species 0.000 description 2
• 241000725177 Omsk hemorrhagic fever virus Species 0.000 description 2
• 241000702244 Orthoreovirus Species 0.000 description 2
• 241000283973 Oryctolagus cuniculus Species 0.000 description 2
• 206010061902 Pancreatic neoplasm Diseases 0.000 description 2
• 241001494479 Pecora Species 0.000 description 2
• 241000150350 Peribunyaviridae Species 0.000 description 2
• 241000710778 Pestivirus Species 0.000 description 2
• NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
• 241000709664 Picornaviridae Species 0.000 description 2
• 241000711902 Pneumovirus Species 0.000 description 2
• 241000710884 Powassan virus Species 0.000 description 2
• 241000700625 Poxviridae Species 0.000 description 2
• 208000000236 Prostatic Neoplasms Diseases 0.000 description 2
• 241000125945 Protoparvovirus Species 0.000 description 2
• 241000711798 Rabies lyssavirus Species 0.000 description 2
• 208000015634 Rectal Neoplasms Diseases 0.000 description 2
• 241000702247 Reoviridae Species 0.000 description 2
• 241000712909 Reticuloendotheliosis virus Species 0.000 description 2
• 241000711931 Rhabdoviridae Species 0.000 description 2
• PYMYPHUHKUWMLA-LMVFSUKVSA-N Ribose Natural products OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 description 2
• 241000713124 Rift Valley fever virus Species 0.000 description 2
• 241000711897 Rinderpest morbillivirus Species 0.000 description 2
• 241000710942 Ross River virus Species 0.000 description 2
• 241000710801 Rubivirus Species 0.000 description 2
• 241001135555 Sandfly fever Sicilian virus Species 0.000 description 2
• 206010039491 Sarcoma Diseases 0.000 description 2
• 241001529934 Simian T-lymphotropic virus 3 Species 0.000 description 2
• 241000713656 Simian foamy virus Species 0.000 description 2
• 241000700584 Simplexvirus Species 0.000 description 2
• 241000710960 Sindbis virus Species 0.000 description 2
• 208000001203 Smallpox Diseases 0.000 description 2
• 241000713896 Spleen necrosis virus Species 0.000 description 2
• 241000710888 St. Louis encephalitis virus Species 0.000 description 2
• 229930182558 Sterol Natural products 0.000 description 2
• 208000005718 Stomach Neoplasms Diseases 0.000 description 2
• 241000282898 Sus scrofa Species 0.000 description 2
• 241000725681 Swine influenza virus Species 0.000 description 2
• GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 2
• 241000710924 Togaviridae Species 0.000 description 2
• 102000004142 Trypsin Human genes 0.000 description 2
• 108090000631 Trypsin Proteins 0.000 description 2
• ISAKRJDGNUQOIC-UHFFFAOYSA-N Uracil Chemical compound O=C1C=CNC(=O)N1 ISAKRJDGNUQOIC-UHFFFAOYSA-N 0.000 description 2
• 241000713152 Uukuniemi virus Species 0.000 description 2
• 206010046865 Vaccinia virus infection Diseases 0.000 description 2
• 241000710959 Venezuelan equine encephalitis virus Species 0.000 description 2
• 241000711970 Vesiculovirus Species 0.000 description 2
• 241000710886 West Nile virus Species 0.000 description 2
• 241000710951 Western equine encephalitis virus Species 0.000 description 2
• 241000714205 Woolly monkey sarcoma virus Species 0.000 description 2
• 241000710772 Yellow fever virus Species 0.000 description 2
• DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 2
• 230000003213 activating effect Effects 0.000 description 2
• 239000004480 active ingredient Substances 0.000 description 2
• 239000000654 additive Substances 0.000 description 2
• 108700010877 adenoviridae proteins Proteins 0.000 description 2
• 239000002671 adjuvant Substances 0.000 description 2
• 230000002411 adverse Effects 0.000 description 2
• HMFHBZSHGGEWLO-UHFFFAOYSA-N alpha-D-Furanose-Ribose Natural products OCC1OC(O)C(O)C1O HMFHBZSHGGEWLO-UHFFFAOYSA-N 0.000 description 2
• 238000010171 animal model Methods 0.000 description 2
• 230000003466 anti-cipated effect Effects 0.000 description 2
• 239000002246 antineoplastic agent Substances 0.000 description 2
• 125000003118 aryl group Chemical group 0.000 description 2
• QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical group [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
• 230000001580 bacterial effect Effects 0.000 description 2
• 230000008901 benefit Effects 0.000 description 2
• 238000004166 bioassay Methods 0.000 description 2
• 229960002685 biotin Drugs 0.000 description 2
• 239000011616 biotin Substances 0.000 description 2
• 210000004369 blood Anatomy 0.000 description 2
• 239000008280 blood Substances 0.000 description 2
• 239000006172 buffering agent Substances 0.000 description 2
• 229910052799 carbon Inorganic materials 0.000 description 2
• 125000002091 cationic group Chemical group 0.000 description 2
• 230000010261 cell growth Effects 0.000 description 2
• 239000001913 cellulose Substances 0.000 description 2
• 229920002678 cellulose Polymers 0.000 description 2
• 235000010980 cellulose Nutrition 0.000 description 2
• 230000008859 change Effects 0.000 description 2
• 239000003153 chemical reaction reagent Substances 0.000 description 2
• OSASVXMJTNOKOY-UHFFFAOYSA-N chlorobutanol Chemical compound CC(C)(O)C(Cl)(Cl)Cl OSASVXMJTNOKOY-UHFFFAOYSA-N 0.000 description 2
• 235000012000 cholesterol Nutrition 0.000 description 2
• 230000001684 chronic effect Effects 0.000 description 2
• 239000002299 complementary DNA Substances 0.000 description 2
• 238000012937 correction Methods 0.000 description 2
• 230000034994 death Effects 0.000 description 2
• 230000003111 delayed effect Effects 0.000 description 2
• 235000014113 dietary fatty acids Nutrition 0.000 description 2
• BOKOVLFWCAFYHP-UHFFFAOYSA-N dihydroxy-methoxy-sulfanylidene-$l^{5}-phosphane Chemical compound COP(O)(O)=S BOKOVLFWCAFYHP-UHFFFAOYSA-N 0.000 description 2
• 239000002552 dosage form Substances 0.000 description 2
• 238000012377 drug delivery Methods 0.000 description 2
• 241001493065 dsRNA viruses Species 0.000 description 2
• 238000000132 electrospray ionisation Methods 0.000 description 2
• 238000002330 electrospray ionisation mass spectrometry Methods 0.000 description 2
• 238000005516 engineering process Methods 0.000 description 2
• 239000000194 fatty acid Substances 0.000 description 2
• 229930195729 fatty acid Natural products 0.000 description 2
• 239000010685 fatty oil Substances 0.000 description 2
• 230000008713 feedback mechanism Effects 0.000 description 2
• 229960002949 fluorouracil Drugs 0.000 description 2
• 206010017758 gastric cancer Diseases 0.000 description 2
• 239000008187 granular material Substances 0.000 description 2
• 230000001894 hemadsorption Effects 0.000 description 2
• FDGQSTZJBFJUBT-UHFFFAOYSA-N hypoxanthine Chemical compound O=C1NC=NC2=C1NC=N2 FDGQSTZJBFJUBT-UHFFFAOYSA-N 0.000 description 2
• 230000036039 immunity Effects 0.000 description 2
• 238000002649 immunization Methods 0.000 description 2
• 230000003053 immunization Effects 0.000 description 2
• 238000002513 implantation Methods 0.000 description 2
• 230000001976 improved effect Effects 0.000 description 2
• 238000011835 investigation Methods 0.000 description 2
• 208000009000 laryngeal papillomatosis Diseases 0.000 description 2
• 230000000670 limiting effect Effects 0.000 description 2
• 239000000314 lubricant Substances 0.000 description 2
• 210000002540 macrophage Anatomy 0.000 description 2
• HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
• 230000003211 malignant effect Effects 0.000 description 2
• 208000015486 malignant pancreatic neoplasm Diseases 0.000 description 2
• 238000004949 mass spectrometry Methods 0.000 description 2
• 239000000463 material Substances 0.000 description 2
• 230000007246 mechanism Effects 0.000 description 2
• 210000003071 memory t lymphocyte Anatomy 0.000 description 2
• VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 2
• 239000011325 microbead Substances 0.000 description 2
• 230000000877 morphologic effect Effects 0.000 description 2
• 201000005962 mycosis fungoides Diseases 0.000 description 2
• 239000002777 nucleoside Substances 0.000 description 2
• 150000003833 nucleoside derivatives Chemical class 0.000 description 2
• 208000008443 pancreatic carcinoma Diseases 0.000 description 2
• 238000007911 parenteral administration Methods 0.000 description 2
• 230000036961 partial effect Effects 0.000 description 2
• 239000002245 particle Substances 0.000 description 2
• 239000012071 phase Substances 0.000 description 2
• PHEDXBVPIONUQT-RGYGYFBISA-N phorbol 13-acetate 12-myristate Chemical compound C([C@]1(O)C(=O)C(C)=C[C@H]1[C@@]1(O)[C@H](C)[C@H]2OC(=O)CCCCCCCCCCCCC)C(CO)=C[C@H]1[C@H]1[C@]2(OC(C)=O)C1(C)C PHEDXBVPIONUQT-RGYGYFBISA-N 0.000 description 2
• 238000001126 phototherapy Methods 0.000 description 2
• 229940115272 polyinosinic:polycytidylic acid Drugs 0.000 description 2
• 230000009696 proliferative response Effects 0.000 description 2
• 230000001737 promoting effect Effects 0.000 description 2
• 230000000069 prophylactic effect Effects 0.000 description 2
• 238000000746 purification Methods 0.000 description 2
• 238000001959 radiotherapy Methods 0.000 description 2
• 206010038038 rectal cancer Diseases 0.000 description 2
• 201000001275 rectum cancer Diseases 0.000 description 2
• 230000011664 signaling Effects 0.000 description 2
• 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 2
• 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 2
• PUZPDOWCWNUUKD-UHFFFAOYSA-M sodium fluoride Chemical compound [F-].[Na+] PUZPDOWCWNUUKD-UHFFFAOYSA-M 0.000 description 2
• 239000002904 solvent Substances 0.000 description 2
• 230000003595 spectral effect Effects 0.000 description 2
• 230000006641 stabilisation Effects 0.000 description 2
• 238000011105 stabilization Methods 0.000 description 2
• 239000008107 starch Substances 0.000 description 2
• 235000003702 sterols Nutrition 0.000 description 2
• 150000003432 sterols Chemical class 0.000 description 2
• 201000011549 stomach cancer Diseases 0.000 description 2
• UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
• 230000001502 supplementing effect Effects 0.000 description 2
• 239000006188 syrup Substances 0.000 description 2
• 235000020357 syrup Nutrition 0.000 description 2
• 239000000454 talc Substances 0.000 description 2
• 229910052623 talc Inorganic materials 0.000 description 2
• 235000012222 talc Nutrition 0.000 description 2
• 238000011269 treatment regimen Methods 0.000 description 2
• 150000003626 triacylglycerols Chemical class 0.000 description 2
• 239000012588 trypsin Substances 0.000 description 2
• 230000003827 upregulation Effects 0.000 description 2
• 208000007089 vaccinia Diseases 0.000 description 2
• 230000002477 vacuolizing effect Effects 0.000 description 2
• 239000000277 virosome Substances 0.000 description 2
• 230000004580 weight loss Effects 0.000 description 2
• 229940051021 yellow-fever virus Drugs 0.000 description 2
• LNAZSHAWQACDHT-XIYTZBAFSA-N (2r,3r,4s,5r,6s)-4,5-dimethoxy-2-(methoxymethyl)-3-[(2s,3r,4s,5r,6r)-3,4,5-trimethoxy-6-(methoxymethyl)oxan-2-yl]oxy-6-[(2r,3r,4s,5r,6r)-4,5,6-trimethoxy-2-(methoxymethyl)oxan-3-yl]oxyoxane Chemical compound CO[C@@H]1[C@@H](OC)[C@H](OC)[C@@H](COC)O[C@H]1O[C@H]1[C@H](OC)[C@@H](OC)[C@H](O[C@H]2[C@@H]([C@@H](OC)[C@H](OC)O[C@@H]2COC)OC)O[C@@H]1COC LNAZSHAWQACDHT-XIYTZBAFSA-N 0.000 description 1
• QIVUCLWGARAQIO-OLIXTKCUSA-N (3s)-n-[(3s,5s,6r)-6-methyl-2-oxo-1-(2,2,2-trifluoroethyl)-5-(2,3,6-trifluorophenyl)piperidin-3-yl]-2-oxospiro[1h-pyrrolo[2,3-b]pyridine-3,6'-5,7-dihydrocyclopenta[b]pyridine]-3'-carboxamide Chemical compound C1([C@H]2[C@H](N(C(=O)[C@@H](NC(=O)C=3C=C4C[C@]5(CC4=NC=3)C3=CC=CN=C3NC5=O)C2)CC(F)(F)F)C)=C(F)C=CC(F)=C1F QIVUCLWGARAQIO-OLIXTKCUSA-N 0.000 description 1
• POVNCJSPYFCWJR-USZUGGBUSA-N (4s)-4-[[(2s)-2-[[(2s)-2-amino-3-(4-hydroxyphenyl)propanoyl]amino]-4-methylpentanoyl]amino]-5-[(2s)-2-[[2-[(2s)-2-[[(2s)-1-[[(2s,3r)-1-[[(1s)-1-carboxy-2-methylpropyl]amino]-3-hydroxy-1-oxobutan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]carbamoyl]pyrrolidin-1- Chemical compound C([C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N1[C@@H](CCC1)C(=O)NCC(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(O)=O)C1=CC=C(O)C=C1 POVNCJSPYFCWJR-USZUGGBUSA-N 0.000 description 1
• 108091032973 (ribonucleotides)n+m Proteins 0.000 description 1
• DDMOUSALMHHKOS-UHFFFAOYSA-N 1,2-dichloro-1,1,2,2-tetrafluoroethane Chemical compound FC(F)(Cl)C(F)(F)Cl DDMOUSALMHHKOS-UHFFFAOYSA-N 0.000 description 1
• IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
• MWBWWFOAEOYUST-UHFFFAOYSA-N 2-aminopurine Chemical compound NC1=NC=C2N=CNC2=N1 MWBWWFOAEOYUST-UHFFFAOYSA-N 0.000 description 1
• ASJSAQIRZKANQN-CRCLSJGQSA-N 2-deoxy-D-ribose Chemical compound OC[C@@H](O)[C@@H](O)CC=O ASJSAQIRZKANQN-CRCLSJGQSA-N 0.000 description 1
• HZLCGUXUOFWCCN-UHFFFAOYSA-N 2-hydroxynonadecane-1,2,3-tricarboxylic acid Chemical compound CCCCCCCCCCCCCCCCC(C(O)=O)C(O)(C(O)=O)CC(O)=O HZLCGUXUOFWCCN-UHFFFAOYSA-N 0.000 description 1
• HFGHRUCCKVYFKL-UHFFFAOYSA-N 4-ethoxy-2-piperazin-1-yl-7-pyridin-4-yl-5h-pyrimido[5,4-b]indole Chemical compound C1=C2NC=3C(OCC)=NC(N4CCNCC4)=NC=3C2=CC=C1C1=CC=NC=C1 HFGHRUCCKVYFKL-UHFFFAOYSA-N 0.000 description 1
• HIYAVKIYRIFSCZ-CYEMHPAKSA-N 5-(methylamino)-2-[[(2S,3R,5R,6S,8R,9R)-3,5,9-trimethyl-2-[(2S)-1-oxo-1-(1H-pyrrol-2-yl)propan-2-yl]-1,7-dioxaspiro[5.5]undecan-8-yl]methyl]-1,3-benzoxazole-4-carboxylic acid Chemical compound O=C([C@@H](C)[C@H]1O[C@@]2([C@@H](C[C@H]1C)C)O[C@@H]([C@@H](CC2)C)CC=1OC2=CC=C(C(=C2N=1)C(O)=O)NC)C1=CC=CN1 HIYAVKIYRIFSCZ-CYEMHPAKSA-N 0.000 description 1
• LRSASMSXMSNRBT-UHFFFAOYSA-N 5-methylcytosine Chemical compound CC1=CNC(=O)N=C1N LRSASMSXMSNRBT-UHFFFAOYSA-N 0.000 description 1
• RYYIULNRIVUMTQ-UHFFFAOYSA-N 6-chloroguanine Chemical compound NC1=NC(Cl)=C2N=CNC2=N1 RYYIULNRIVUMTQ-UHFFFAOYSA-N 0.000 description 1
• VVIAGPKUTFNRDU-UHFFFAOYSA-N 6S-folinic acid Natural products C1NC=2NC(N)=NC(=O)C=2N(C=O)C1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 VVIAGPKUTFNRDU-UHFFFAOYSA-N 0.000 description 1
• MSSXOMSJDRHRMC-UHFFFAOYSA-N 9H-purine-2,6-diamine Chemical compound NC1=NC(N)=C2NC=NC2=N1 MSSXOMSJDRHRMC-UHFFFAOYSA-N 0.000 description 1
• 244000215068 Acacia senegal Species 0.000 description 1
• 241000120516 African horse sickness virus Species 0.000 description 1
• 229920001817 Agar Polymers 0.000 description 1
• 241001135972 Aleutian mink disease virus Species 0.000 description 1
• GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
• 241000710929 Alphavirus Species 0.000 description 1
• 102000006306 Antigen Receptors Human genes 0.000 description 1
• 108010083359 Antigen Receptors Proteins 0.000 description 1
• 241000269350 Anura Species 0.000 description 1
• 241000416162 Astragalus gummifer Species 0.000 description 1
• 241000701061 Ateline gammaherpesvirus 2 Species 0.000 description 1
• 241000972773 Aulopiformes Species 0.000 description 1
• 241000701802 Aviadenovirus Species 0.000 description 1
• 241001213911 Avian retroviruses Species 0.000 description 1
• 241000700663 Avipoxvirus Species 0.000 description 1
• 102100022005 B-lymphocyte antigen CD20 Human genes 0.000 description 1
• 241000193830 Bacillus <bacterium> Species 0.000 description 1
• 208000035143 Bacterial infection Diseases 0.000 description 1
• 241000702628 Birnaviridae Species 0.000 description 1
• 206010005003 Bladder cancer Diseases 0.000 description 1
• 241000120506 Bluetongue virus Species 0.000 description 1
• 241000701083 Bovine alphaherpesvirus 1 Species 0.000 description 1
• 241000701822 Bovine papillomavirus Species 0.000 description 1
• 241000621124 Bovine papular stomatitis virus Species 0.000 description 1
• 241000701922 Bovine parvovirus Species 0.000 description 1
• 241001506128 Bovine rotavirus strain NCDV/G6 Species 0.000 description 1
• 208000003174 Brain Neoplasms Diseases 0.000 description 1
• 206010006187 Breast cancer Diseases 0.000 description 1
• 208000026310 Breast neoplasm Diseases 0.000 description 1
• 102000017420 CD3 protein, epsilon/gamma/delta subunit Human genes 0.000 description 1
• 108050005493 CD3 protein, epsilon/gamma/delta subunit Proteins 0.000 description 1
• 210000001266 CD8-positive T-lymphocyte Anatomy 0.000 description 1
• 241000701931 Canine parvovirus Species 0.000 description 1
• 241000283707 Capra Species 0.000 description 1
• 241000700664 Capripoxvirus Species 0.000 description 1
• 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
• 208000009458 Carcinoma in Situ Diseases 0.000 description 1
• 241000710190 Cardiovirus Species 0.000 description 1
• DLGOEMSEDOSKAD-UHFFFAOYSA-N Carmustine Chemical compound ClCCNC(=O)N(N=O)CCCl DLGOEMSEDOSKAD-UHFFFAOYSA-N 0.000 description 1
• 241000700199 Cavia porcellus Species 0.000 description 1
• 206010008342 Cervix carcinoma Diseases 0.000 description 1
• 241000711969 Chandipura virus Species 0.000 description 1
• 108010012236 Chemokines Proteins 0.000 description 1
• 102000019034 Chemokines Human genes 0.000 description 1
• 229920001661 Chitosan Polymers 0.000 description 1
• 208000006332 Choriocarcinoma Diseases 0.000 description 1
• 208000000419 Chronic Hepatitis B Diseases 0.000 description 1
• 208000006154 Chronic hepatitis C Diseases 0.000 description 1
• 102000007644 Colony-Stimulating Factors Human genes 0.000 description 1
• 108010071942 Colony-Stimulating Factors Proteins 0.000 description 1
• 241000204955 Colorado tick fever virus Species 0.000 description 1
• 206010052358 Colorectal cancer metastatic Diseases 0.000 description 1
• 108010062580 Concanavalin A Proteins 0.000 description 1
• 229920002261 Corn starch Polymers 0.000 description 1
• 241000711573 Coronaviridae Species 0.000 description 1
• 241000709687 Coxsackievirus Species 0.000 description 1
• 208000020406 Creutzfeldt Jacob disease Diseases 0.000 description 1
• 208000003407 Creutzfeldt-Jakob Syndrome Diseases 0.000 description 1
• 208000010859 Creutzfeldt-Jakob disease Diseases 0.000 description 1
• 102100025621 Cytochrome b-245 heavy chain Human genes 0.000 description 1
• FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
• 241000710829 Dengue virus group Species 0.000 description 1
• 241000702421 Dependoparvovirus Species 0.000 description 1
• 201000004624 Dermatitis Diseases 0.000 description 1
• 229920002307 Dextran Polymers 0.000 description 1
• 239000004338 Dichlorodifluoromethane Substances 0.000 description 1
• KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
• 241000710945 Eastern equine encephalitis virus Species 0.000 description 1
• 241001466953 Echovirus Species 0.000 description 1
• 208000006586 Ectromelia Diseases 0.000 description 1
• LVGKNOAMLMIIKO-UHFFFAOYSA-N Elaidinsaeure-aethylester Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC LVGKNOAMLMIIKO-UHFFFAOYSA-N 0.000 description 1
• 241000196324 Embryophyta Species 0.000 description 1
• 241000710188 Encephalomyocarditis virus Species 0.000 description 1
• 206010014733 Endometrial cancer Diseases 0.000 description 1
• 206010014759 Endometrial neoplasm Diseases 0.000 description 1
• 241000792859 Enema Species 0.000 description 1
• 241000988559 Enterovirus A Species 0.000 description 1
• 241000709691 Enterovirus E Species 0.000 description 1
• 241000701081 Equid alphaherpesvirus 1 Species 0.000 description 1
• 241001598169 Equid alphaherpesvirus 3 Species 0.000 description 1
• 241000725578 Equid gammaherpesvirus 2 Species 0.000 description 1
• 208000000832 Equine Encephalomyelitis Diseases 0.000 description 1
• 102000003951 Erythropoietin Human genes 0.000 description 1
• 108090000394 Erythropoietin Proteins 0.000 description 1
• 208000000461 Esophageal Neoplasms Diseases 0.000 description 1
• 241000206602 Eukaryota Species 0.000 description 1
• DSIFMINXCSHZPQ-UHFFFAOYSA-M FUN-1 Chemical compound [I-].S1C2=CC=CC=C2[N+](C)=C1C=C(C1=CC=CC=C11)C=C(Cl)N1C1=CC=CC=C1 DSIFMINXCSHZPQ-UHFFFAOYSA-M 0.000 description 1
• 241000725579 Feline coronavirus Species 0.000 description 1
• 241000701915 Feline panleukopenia virus Species 0.000 description 1
• 241001280522 Feline picornavirus Species 0.000 description 1
• 241000282324 Felis Species 0.000 description 1
• 241000282326 Felis catus Species 0.000 description 1
• 241000711950 Filoviridae Species 0.000 description 1
• 238000012413 Fluorescence activated cell sorting analysis Methods 0.000 description 1
• GHASVSINZRGABV-UHFFFAOYSA-N Fluorouracil Chemical compound FC1=CNC(=O)NC1=O GHASVSINZRGABV-UHFFFAOYSA-N 0.000 description 1
• 208000007212 Foot-and-Mouth Disease Diseases 0.000 description 1
• 208000000666 Fowlpox Diseases 0.000 description 1
• 241000701063 Gallid alphaherpesvirus 1 Species 0.000 description 1
• 241000701047 Gallid alphaherpesvirus 2 Species 0.000 description 1
• 241000287828 Gallus gallus Species 0.000 description 1
• 208000005577 Gastroenteritis Diseases 0.000 description 1
• 208000032612 Glial tumor Diseases 0.000 description 1
• 206010018338 Glioma Diseases 0.000 description 1
• 229930186217 Glycolipid Natural products 0.000 description 1
• 102000003886 Glycoproteins Human genes 0.000 description 1
• 108090000288 Glycoproteins Proteins 0.000 description 1
• 108060003393 Granulin Proteins 0.000 description 1
• 102000004269 Granulocyte Colony-Stimulating Factor Human genes 0.000 description 1
• 108010017080 Granulocyte Colony-Stimulating Factor Proteins 0.000 description 1
• 108010051696 Growth Hormone Proteins 0.000 description 1
• 229920000084 Gum arabic Polymers 0.000 description 1
• 208000031886 HIV Infections Diseases 0.000 description 1
• 206010061192 Haemorrhagic fever Diseases 0.000 description 1
• 241000150562 Hantaan orthohantavirus Species 0.000 description 1
• 241000700739 Hepadnaviridae Species 0.000 description 1
• 208000005331 Hepatitis D Diseases 0.000 description 1
• 208000007514 Herpes zoster Diseases 0.000 description 1
• 241000701020 Herpesvirus sylvilagus Species 0.000 description 1
• 208000017604 Hodgkin disease Diseases 0.000 description 1
• 208000021519 Hodgkin lymphoma Diseases 0.000 description 1
• 208000010747 Hodgkins lymphoma Diseases 0.000 description 1
• 101000897405 Homo sapiens B-lymphocyte antigen CD20 Proteins 0.000 description 1
• 101000599951 Homo sapiens Insulin-like growth factor I Proteins 0.000 description 1
• 101001055222 Homo sapiens Interleukin-8 Proteins 0.000 description 1
• 101000946850 Homo sapiens T-lymphocyte activation antigen CD86 Proteins 0.000 description 1
• 241000714260 Human T-lymphotropic virus 1 Species 0.000 description 1
• 241000701085 Human alphaherpesvirus 3 Species 0.000 description 1
• 241000701024 Human betaherpesvirus 5 Species 0.000 description 1
• 244000309469 Human enteric coronavirus Species 0.000 description 1
• 241000713340 Human immunodeficiency virus 2 Species 0.000 description 1
• 241000701806 Human papillomavirus Species 0.000 description 1
• 241000829111 Human polyomavirus 1 Species 0.000 description 1
• 241000430519 Human rhinovirus sp. Species 0.000 description 1
• 241000617996 Human rotavirus Species 0.000 description 1
• UGQMRVRMYYASKQ-UHFFFAOYSA-N Hypoxanthine nucleoside Natural products OC1C(O)C(CO)OC1N1C(NC=NC2=O)=C2N=C1 UGQMRVRMYYASKQ-UHFFFAOYSA-N 0.000 description 1
• DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
• 208000004467 Infectious Canine Hepatitis Diseases 0.000 description 1
• 102100037852 Insulin-like growth factor I Human genes 0.000 description 1
• 108010064593 Intercellular Adhesion Molecule-1 Proteins 0.000 description 1
• 102000005755 Intercellular Signaling Peptides and Proteins Human genes 0.000 description 1
• 108010070716 Intercellular Signaling Peptides and Proteins Proteins 0.000 description 1
• 102100037877 Intercellular adhesion molecule 1 Human genes 0.000 description 1
• 102000003996 Interferon-beta Human genes 0.000 description 1
• 108090000467 Interferon-beta Proteins 0.000 description 1
• 108010002352 Interleukin-1 Proteins 0.000 description 1
• 102000000589 Interleukin-1 Human genes 0.000 description 1
• 102000014154 Interleukin-12 Subunit p35 Human genes 0.000 description 1
• 108010011301 Interleukin-12 Subunit p35 Proteins 0.000 description 1
• 108010038452 Interleukin-3 Receptors Proteins 0.000 description 1
• 102000010790 Interleukin-3 Receptors Human genes 0.000 description 1
• 108090000978 Interleukin-4 Proteins 0.000 description 1
• 241000701460 JC polyomavirus Species 0.000 description 1
• 241000701646 Kappapapillomavirus 2 Species 0.000 description 1
• 241000120527 Kemerovo virus Species 0.000 description 1
• 208000008839 Kidney Neoplasms Diseases 0.000 description 1
• ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
• 229930182816 L-glutamine Natural products 0.000 description 1
• 238000011050 LAL assay Methods 0.000 description 1
• 241000186660 Lactobacillus Species 0.000 description 1
• 241000712902 Lassa mammarenavirus Species 0.000 description 1
• 241000700563 Leporipoxvirus Species 0.000 description 1
• 206010024503 Limb reduction defect Diseases 0.000 description 1
• 206010058467 Lung neoplasm malignant Diseases 0.000 description 1
• 206010025323 Lymphomas Diseases 0.000 description 1
• 241000711828 Lyssavirus Species 0.000 description 1
• 102000043129 MHC class I family Human genes 0.000 description 1
• 108091054437 MHC class I family Proteins 0.000 description 1
• 235000019759 Maize starch Nutrition 0.000 description 1
• 229930195725 Mannitol Natural products 0.000 description 1
• 241001115401 Marburgvirus Species 0.000 description 1
• 241000701244 Mastadenovirus Species 0.000 description 1
• 241000710185 Mengo virus Species 0.000 description 1
• 241000713333 Mouse mammary tumor virus Species 0.000 description 1
• 208000003445 Mouth Neoplasms Diseases 0.000 description 1
• 241001529936 Murinae Species 0.000 description 1
• 241000711466 Murine hepatitis virus Species 0.000 description 1
• 241001135960 Murine rotavirus Species 0.000 description 1
• 206010062207 Mycobacterial infection Diseases 0.000 description 1
• 101001055320 Myxine glutinosa Insulin-like growth factor Proteins 0.000 description 1
• 102000015336 Nerve Growth Factor Human genes 0.000 description 1
• 108010025020 Nerve Growth Factor Proteins 0.000 description 1
• 206010029260 Neuroblastoma Diseases 0.000 description 1
• 208000015914 Non-Hodgkin lymphomas Diseases 0.000 description 1
• 238000000636 Northern blotting Methods 0.000 description 1
• 241000714209 Norwalk virus Species 0.000 description 1
• 108700001237 Nucleic Acid-Based Vaccines Proteins 0.000 description 1
• QWZRZYWLWTWVLF-UHFFFAOYSA-N O.OP(O)=O Chemical compound O.OP(O)=O QWZRZYWLWTWVLF-UHFFFAOYSA-N 0.000 description 1
• 206010030155 Oesophageal carcinoma Diseases 0.000 description 1
• 241000702259 Orbivirus Species 0.000 description 1
• 241000700629 Orthopoxvirus Species 0.000 description 1
• 101710160107 Outer membrane protein A Proteins 0.000 description 1
• 206010033128 Ovarian cancer Diseases 0.000 description 1
• 206010061535 Ovarian neoplasm Diseases 0.000 description 1
• 241000700639 Parapoxvirus Species 0.000 description 1
• 206010033976 Paravaccinia Diseases 0.000 description 1
• 241000701945 Parvoviridae Species 0.000 description 1
• 229930182555 Penicillin Natural products 0.000 description 1
• JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
• 108010033276 Peptide Fragments Proteins 0.000 description 1
• 102000007079 Peptide Fragments Human genes 0.000 description 1
• 241000009328 Perro Species 0.000 description 1
• 229920002732 Polyanhydride Polymers 0.000 description 1
• 239000002202 Polyethylene glycol Substances 0.000 description 1
• 229920001710 Polyorthoester Polymers 0.000 description 1
• ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
• 208000006994 Precancerous Conditions Diseases 0.000 description 1
• 241000288906 Primates Species 0.000 description 1
• 208000024777 Prion disease Diseases 0.000 description 1
• KDCGOANMDULRCW-UHFFFAOYSA-N Purine Natural products N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 1
• 108010092799 RNA-directed DNA polymerase Proteins 0.000 description 1
• 239000012980 RPMI-1640 medium Substances 0.000 description 1
• 238000011529 RT qPCR Methods 0.000 description 1
• 241000700159 Rattus Species 0.000 description 1
• 108020004511 Recombinant DNA Proteins 0.000 description 1
• 108010008281 Recombinant Fusion Proteins Proteins 0.000 description 1
• 102000007056 Recombinant Fusion Proteins Human genes 0.000 description 1
• 206010038389 Renal cancer Diseases 0.000 description 1
• 208000037656 Respiratory Sounds Diseases 0.000 description 1
• 241000712907 Retroviridae Species 0.000 description 1
• 206010051497 Rhinotracheitis Diseases 0.000 description 1
• IWUCXVSUMQZMFG-AFCXAGJDSA-N Ribavirin Chemical compound N1=C(C(=O)N)N=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1 IWUCXVSUMQZMFG-AFCXAGJDSA-N 0.000 description 1
• 241000283984 Rodentia Species 0.000 description 1
• 241000282695 Saimiri Species 0.000 description 1
• 241000607142 Salmonella Species 0.000 description 1
• 241000293869 Salmonella enterica subsp. enterica serovar Typhimurium Species 0.000 description 1
• 241000714213 San Miguel sea lion virus Species 0.000 description 1
• 241000710961 Semliki Forest virus Species 0.000 description 1
• 208000009359 Sezary Syndrome Diseases 0.000 description 1
• 241000607768 Shigella Species 0.000 description 1
• 241000702677 Simian rotavirus Species 0.000 description 1
• 208000000453 Skin Neoplasms Diseases 0.000 description 1
• 206010041067 Small cell lung cancer Diseases 0.000 description 1
• 229920002125 Sokalan® Polymers 0.000 description 1
• 102100038803 Somatotropin Human genes 0.000 description 1
• 229930006000 Sucrose Natural products 0.000 description 1
• CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
• 241000701093 Suid alphaherpesvirus 1 Species 0.000 description 1
• 241000282887 Suidae Species 0.000 description 1
• 241000700568 Suipoxvirus Species 0.000 description 1
• 230000006044 T cell activation Effects 0.000 description 1
• 108091008874 T cell receptors Proteins 0.000 description 1
• 230000005867 T cell response Effects 0.000 description 1
• 102000016266 T-Cell Antigen Receptors Human genes 0.000 description 1
• 208000031673 T-Cell Cutaneous Lymphoma Diseases 0.000 description 1
• 230000029662 T-helper 1 type immune response Effects 0.000 description 1
• 102100034924 T-lymphocyte activation antigen CD86 Human genes 0.000 description 1
• 241000712908 Tacaribe mammarenavirus Species 0.000 description 1
• 208000024313 Testicular Neoplasms Diseases 0.000 description 1
• 206010057644 Testis cancer Diseases 0.000 description 1
• RYYWUUFWQRZTIU-UHFFFAOYSA-N Thiophosphoric acid Chemical class OP(O)(S)=O RYYWUUFWQRZTIU-UHFFFAOYSA-N 0.000 description 1
• 102000036693 Thrombopoietin Human genes 0.000 description 1
• 108010041111 Thrombopoietin Proteins 0.000 description 1
• 208000024770 Thyroid neoplasm Diseases 0.000 description 1
• YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 1
• 229920001615 Tragacanth Polymers 0.000 description 1
• 239000007984 Tris EDTA buffer Substances 0.000 description 1
• GLNADSQYFUSGOU-GPTZEZBUSA-J Trypan blue Chemical compound [Na+].[Na+].[Na+].[Na+].C1=C(S([O-])(=O)=O)C=C2C=C(S([O-])(=O)=O)C(/N=N/C3=CC=C(C=C3C)C=3C=C(C(=CC=3)\N=N\C=3C(=CC4=CC(=CC(N)=C4C=3O)S([O-])(=O)=O)S([O-])(=O)=O)C)=C(O)C2=C1N GLNADSQYFUSGOU-GPTZEZBUSA-J 0.000 description 1
• 208000007097 Urinary Bladder Neoplasms Diseases 0.000 description 1
• 208000006105 Uterine Cervical Neoplasms Diseases 0.000 description 1
• 241000700618 Vaccinia virus Species 0.000 description 1
• 241000700647 Variola virus Species 0.000 description 1
• 241001494970 Vesicular exanthema of swine virus Species 0.000 description 1
• 241000713325 Visna/maedi virus Species 0.000 description 1
• 241000120645 Yellow fever virus group Species 0.000 description 1
• 235000010489 acacia gum Nutrition 0.000 description 1
• 239000000205 acacia gum Substances 0.000 description 1
• 230000001154 acute effect Effects 0.000 description 1
• 230000000996 additive effect Effects 0.000 description 1
• 238000009098 adjuvant therapy Methods 0.000 description 1
• 239000008272 agar Substances 0.000 description 1
• 235000010419 agar Nutrition 0.000 description 1
• 229940040563 agaric acid Drugs 0.000 description 1
• 235000010443 alginic acid Nutrition 0.000 description 1
• 229920000615 alginic acid Polymers 0.000 description 1
• 239000000783 alginic acid Substances 0.000 description 1
• 229960001126 alginic acid Drugs 0.000 description 1
• 150000004781 alginic acids Chemical class 0.000 description 1
• 125000000217 alkyl group Chemical group 0.000 description 1
• 125000005600 alkyl phosphonate group Chemical group 0.000 description 1
• 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
• DKNWSYNQZKUICI-UHFFFAOYSA-N amantadine Chemical compound C1C(C2)CC3CC2CC1(N)C3 DKNWSYNQZKUICI-UHFFFAOYSA-N 0.000 description 1
• 229960003805 amantadine Drugs 0.000 description 1
• 150000001413 amino acids Chemical group 0.000 description 1
• 208000007502 anemia Diseases 0.000 description 1
• 208000025009 anogenital human papillomavirus infection Diseases 0.000 description 1
• 201000004201 anogenital venereal wart Diseases 0.000 description 1
• 230000001093 anti-cancer Effects 0.000 description 1
• 230000001028 anti-proliverative effect Effects 0.000 description 1
• 230000000840 anti-viral effect Effects 0.000 description 1
• 230000030741 antigen processing and presentation Effects 0.000 description 1
• 229940041181 antineoplastic drug Drugs 0.000 description 1
• 239000000074 antisense oligonucleotide Substances 0.000 description 1
• 238000012230 antisense oligonucleotides Methods 0.000 description 1
• 239000003443 antiviral agent Substances 0.000 description 1
• 230000006907 apoptotic process Effects 0.000 description 1
• 244000144974 aquaculture Species 0.000 description 1
• 239000007864 aqueous solution Substances 0.000 description 1
• 239000008135 aqueous vehicle Substances 0.000 description 1
• PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 description 1
• PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 1
• 244000309743 astrovirus Species 0.000 description 1
• 230000003416 augmentation Effects 0.000 description 1
• 230000003305 autocrine Effects 0.000 description 1
• 230000001363 autoimmune Effects 0.000 description 1
• 241000701792 avian adenovirus Species 0.000 description 1
• 208000022362 bacterial infectious disease Diseases 0.000 description 1
• 210000003651 basophil Anatomy 0.000 description 1
• 229960000686 benzalkonium chloride Drugs 0.000 description 1
• CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 1
• SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 1
• 201000009036 biliary tract cancer Diseases 0.000 description 1
• 208000020790 biliary tract neoplasm Diseases 0.000 description 1
• 229920013641 bioerodible polymer Polymers 0.000 description 1
• 230000004071 biological effect Effects 0.000 description 1
• 230000033228 biological regulation Effects 0.000 description 1
• 210000000601 blood cell Anatomy 0.000 description 1
• KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 1
• 239000004327 boric acid Substances 0.000 description 1
• 229910000019 calcium carbonate Inorganic materials 0.000 description 1
• KVUAALJSMIVURS-ZEDZUCNESA-L calcium folinate Chemical compound [Ca+2].C1NC=2NC(N)=NC(=O)C=2N(C=O)C1CNC1=CC=C(C(=O)N[C@@H](CCC([O-])=O)C([O-])=O)C=C1 KVUAALJSMIVURS-ZEDZUCNESA-L 0.000 description 1
• HIYAVKIYRIFSCZ-UHFFFAOYSA-N calcium ionophore A23187 Natural products N=1C2=C(C(O)=O)C(NC)=CC=C2OC=1CC(C(CC1)C)OC1(C(CC1C)C)OC1C(C)C(=O)C1=CC=CN1 HIYAVKIYRIFSCZ-UHFFFAOYSA-N 0.000 description 1
• 239000001506 calcium phosphate Substances 0.000 description 1
• 229910000389 calcium phosphate Inorganic materials 0.000 description 1
• 235000011010 calcium phosphates Nutrition 0.000 description 1
• 159000000007 calcium salts Chemical class 0.000 description 1
• 238000004364 calculation method Methods 0.000 description 1
• 150000001720 carbohydrates Chemical class 0.000 description 1
• 235000014633 carbohydrates Nutrition 0.000 description 1
• 239000001569 carbon dioxide Substances 0.000 description 1
• 229910002092 carbon dioxide Inorganic materials 0.000 description 1
• 229960004424 carbon dioxide Drugs 0.000 description 1
• 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
• 125000002843 carboxylic acid group Chemical group 0.000 description 1
• 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
• 230000001413 cellular effect Effects 0.000 description 1
• 230000030570 cellular localization Effects 0.000 description 1
• 201000010881 cervical cancer Diseases 0.000 description 1
• 229960004926 chlorobutanol Drugs 0.000 description 1
• 150000001840 cholesterol esters Chemical class 0.000 description 1
• 208000016532 chronic granulomatous disease Diseases 0.000 description 1
• 238000003776 cleavage reaction Methods 0.000 description 1
• 238000010367 cloning Methods 0.000 description 1
• 239000011248 coating agent Substances 0.000 description 1
• 229940110456 cocoa butter Drugs 0.000 description 1
• 235000019868 cocoa butter Nutrition 0.000 description 1
• 208000029742 colonic neoplasm Diseases 0.000 description 1
• 239000007891 compressed tablet Substances 0.000 description 1
• 238000004590 computer program Methods 0.000 description 1
• 201000005332 contagious pustular dermatitis Diseases 0.000 description 1
• 238000011254 conventional chemotherapy Methods 0.000 description 1
• 230000002596 correlated effect Effects 0.000 description 1
• 201000003740 cowpox Diseases 0.000 description 1
• 239000006071 cream Substances 0.000 description 1
• 238000004132 cross linking Methods 0.000 description 1
• 230000001186 cumulative effect Effects 0.000 description 1
• 201000007241 cutaneous T cell lymphoma Diseases 0.000 description 1
• 230000000120 cytopathologic effect Effects 0.000 description 1
• 229940127089 cytotoxic agent Drugs 0.000 description 1
• 238000011393 cytotoxic chemotherapy Methods 0.000 description 1
• 231100000135 cytotoxicity Toxicity 0.000 description 1
• 230000003013 cytotoxicity Effects 0.000 description 1
• 230000007123 defense Effects 0.000 description 1
• 230000002950 deficient Effects 0.000 description 1
• 239000003405 delayed action preparation Substances 0.000 description 1
• 238000000432 density-gradient centrifugation Methods 0.000 description 1
• 238000003795 desorption Methods 0.000 description 1
• 238000011161 development Methods 0.000 description 1
• PXBRQCKWGAHEHS-UHFFFAOYSA-N dichlorodifluoromethane Chemical compound FC(F)(Cl)Cl PXBRQCKWGAHEHS-UHFFFAOYSA-N 0.000 description 1
• 235000019404 dichlorodifluoromethane Nutrition 0.000 description 1
• 229940042935 dichlorodifluoromethane Drugs 0.000 description 1
• 229940087091 dichlorotetrafluoroethane Drugs 0.000 description 1
• 238000010790 dilution Methods 0.000 description 1
• 239000012895 dilution Substances 0.000 description 1
• 150000002009 diols Chemical class 0.000 description 1
• 239000007884 disintegrant Substances 0.000 description 1
• BFMYDTVEBKDAKJ-UHFFFAOYSA-L disodium;(2',7'-dibromo-3',6'-dioxido-3-oxospiro[2-benzofuran-1,9'-xanthene]-4'-yl)mercury;hydrate Chemical compound O.[Na+].[Na+].O1C(=O)C2=CC=CC=C2C21C1=CC(Br)=C([O-])C([Hg])=C1OC1=C2C=C(Br)C([O-])=C1 BFMYDTVEBKDAKJ-UHFFFAOYSA-L 0.000 description 1
• 239000002270 dispersing agent Substances 0.000 description 1
• 231100000673 dose–response relationship Toxicity 0.000 description 1
• 230000003828 downregulation Effects 0.000 description 1
• 239000006196 drop Substances 0.000 description 1
• 239000012636 effector Substances 0.000 description 1
• 206010014599 encephalitis Diseases 0.000 description 1
• 201000002491 encephalomyelitis Diseases 0.000 description 1
• 239000007920 enema Substances 0.000 description 1
• 229940079360 enema for constipation Drugs 0.000 description 1
• 210000003743 erythrocyte Anatomy 0.000 description 1
• 229940105423 erythropoietin Drugs 0.000 description 1
• 201000004101 esophageal cancer Diseases 0.000 description 1
• LVGKNOAMLMIIKO-QXMHVHEDSA-N ethyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC LVGKNOAMLMIIKO-QXMHVHEDSA-N 0.000 description 1
• 229940093471 ethyl oleate Drugs 0.000 description 1
• ZJXZSIYSNXKHEA-UHFFFAOYSA-L ethyl phosphate(2-) Chemical compound CCOP([O-])([O-])=O ZJXZSIYSNXKHEA-UHFFFAOYSA-L 0.000 description 1
• 238000011156 evaluation Methods 0.000 description 1
• 230000005284 excitation Effects 0.000 description 1
• 230000007717 exclusion Effects 0.000 description 1
• 230000001747 exhibiting effect Effects 0.000 description 1
• 230000008622 extracellular signaling Effects 0.000 description 1
• 239000003925 fat Substances 0.000 description 1
• 235000019197 fats Nutrition 0.000 description 1
• 150000004665 fatty acids Chemical class 0.000 description 1
• 208000005098 feline infectious peritonitis Diseases 0.000 description 1
• 206010016629 fibroma Diseases 0.000 description 1
• 239000012997 ficoll-paque Substances 0.000 description 1
• 108700014844 flt3 ligand Proteins 0.000 description 1
• 235000008191 folinic acid Nutrition 0.000 description 1
• 239000011672 folinic acid Substances 0.000 description 1
• 230000037406 food intake Effects 0.000 description 1
• 235000003599 food sweetener Nutrition 0.000 description 1
• 239000012634 fragment Substances 0.000 description 1
• 238000011990 functional testing Methods 0.000 description 1
• 108020001507 fusion proteins Proteins 0.000 description 1
• 102000037865 fusion proteins Human genes 0.000 description 1
• 229940044627 gamma-interferon Drugs 0.000 description 1
• 239000007789 gas Substances 0.000 description 1
• 230000002068 genetic effect Effects 0.000 description 1
• 125000005456 glyceride group Chemical group 0.000 description 1
• PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
• 239000010931 gold Substances 0.000 description 1
• 229910052737 gold Inorganic materials 0.000 description 1
• 238000000227 grinding Methods 0.000 description 1
• 239000000122 growth hormone Substances 0.000 description 1
• 239000001963 growth medium Substances 0.000 description 1
• 238000003306 harvesting Methods 0.000 description 1
• 208000006454 hepatitis Diseases 0.000 description 1
• 231100000283 hepatitis Toxicity 0.000 description 1
• 208000010710 hepatitis C virus infection Diseases 0.000 description 1
• 208000029570 hepatitis D virus infection Diseases 0.000 description 1
• IIRDTKBZINWQAW-UHFFFAOYSA-N hexaethylene glycol Chemical compound OCCOCCOCCOCCOCCOCCO IIRDTKBZINWQAW-UHFFFAOYSA-N 0.000 description 1
• 239000005556 hormone Substances 0.000 description 1
• 229940088597 hormone Drugs 0.000 description 1
• 230000004727 humoral immunity Effects 0.000 description 1
• 239000000017 hydrogel Substances 0.000 description 1
• 230000002209 hydrophobic effect Effects 0.000 description 1
• 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
• 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 1
• 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 1
• 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 1
• UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 1
• 208000003532 hypothyroidism Diseases 0.000 description 1
• 230000002989 hypothyroidism Effects 0.000 description 1
• 230000002519 immonomodulatory effect Effects 0.000 description 1
• 230000005965 immune activity Effects 0.000 description 1
• 238000003364 immunohistochemistry Methods 0.000 description 1
• 239000007943 implant Substances 0.000 description 1
• 238000012606 in vitro cell culture Methods 0.000 description 1
• 238000011065 in-situ storage Methods 0.000 description 1
• 230000004968 inflammatory condition Effects 0.000 description 1
• 108010061181 influenza matrix peptide (58-66) Proteins 0.000 description 1
• 239000007972 injectable composition Substances 0.000 description 1
• 108010006088 interferon alfa-n1 Proteins 0.000 description 1
• 229960003130 interferon gamma Drugs 0.000 description 1
• 102000044166 interleukin-18 binding protein Human genes 0.000 description 1
• 108010070145 interleukin-18 binding protein Proteins 0.000 description 1
• 230000007154 intracellular accumulation Effects 0.000 description 1
• 238000007918 intramuscular administration Methods 0.000 description 1
• 230000002601 intratumoral effect Effects 0.000 description 1
• 238000001990 intravenous administration Methods 0.000 description 1
• 239000003456 ion exchange resin Substances 0.000 description 1
• 229920003303 ion-exchange polymer Polymers 0.000 description 1
• FZWBNHMXJMCXLU-BLAUPYHCSA-N isomaltotriose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O)O1 FZWBNHMXJMCXLU-BLAUPYHCSA-N 0.000 description 1
• 206010023332 keratitis Diseases 0.000 description 1
• 201000010666 keratoconjunctivitis Diseases 0.000 description 1
• 201000010982 kidney cancer Diseases 0.000 description 1
• 206010023497 kuru Diseases 0.000 description 1
• 239000004922 lacquer Substances 0.000 description 1
• 229940039696 lactobacillus Drugs 0.000 description 1
• 229960001691 leucovorin Drugs 0.000 description 1
• 239000003446 ligand Substances 0.000 description 1
• 208000012987 lip and oral cavity carcinoma Diseases 0.000 description 1
• 229940057995 liquid paraffin Drugs 0.000 description 1
• 210000004185 liver Anatomy 0.000 description 1
• 201000007270 liver cancer Diseases 0.000 description 1
• 208000014018 liver neoplasm Diseases 0.000 description 1
• 239000007937 lozenge Substances 0.000 description 1
• 201000005202 lung cancer Diseases 0.000 description 1
• 208000020816 lung neoplasm Diseases 0.000 description 1
• 230000000527 lymphocytic effect Effects 0.000 description 1
• 235000019359 magnesium stearate Nutrition 0.000 description 1
• 230000014759 maintenance of location Effects 0.000 description 1
• 208000006178 malignant mesothelioma Diseases 0.000 description 1
• 201000005282 malignant pleural mesothelioma Diseases 0.000 description 1
• 239000000594 mannitol Substances 0.000 description 1
• 235000010355 mannitol Nutrition 0.000 description 1
• 238000005259 measurement Methods 0.000 description 1
• 229910052751 metal Inorganic materials 0.000 description 1
• 239000002184 metal Substances 0.000 description 1
• 229920000609 methyl cellulose Polymers 0.000 description 1
• 239000001923 methylcellulose Substances 0.000 description 1
• 235000010981 methylcellulose Nutrition 0.000 description 1
• 230000000813 microbial effect Effects 0.000 description 1
• 239000003094 microcapsule Substances 0.000 description 1
• 230000011278 mitosis Effects 0.000 description 1
• 238000010369 molecular cloning Methods 0.000 description 1
• 208000005871 monkeypox Diseases 0.000 description 1
• 201000006417 multiple sclerosis Diseases 0.000 description 1
• 208000027531 mycobacterial infectious disease Diseases 0.000 description 1
• 210000001167 myeloblast Anatomy 0.000 description 1
• 208000009091 myxoma Diseases 0.000 description 1
• 239000005445 natural material Substances 0.000 description 1
• 239000006199 nebulizer Substances 0.000 description 1
• 239000013642 negative control Substances 0.000 description 1
• 230000002981 neuropathic effect Effects 0.000 description 1
• 230000007935 neutral effect Effects 0.000 description 1
• 208000004235 neutropenia Diseases 0.000 description 1
• 238000007899 nucleic acid hybridization Methods 0.000 description 1
• 229940023146 nucleic acid vaccine Drugs 0.000 description 1
• 239000003921 oil Substances 0.000 description 1
• 235000019198 oils Nutrition 0.000 description 1
• 229940124276 oligodeoxyribonucleotide Drugs 0.000 description 1
• 238000002515 oligonucleotide synthesis Methods 0.000 description 1
• 150000007530 organic bases Chemical class 0.000 description 1
• 125000000962 organic group Chemical group 0.000 description 1
• 239000003960 organic solvent Substances 0.000 description 1
• 239000003791 organic solvent mixture Substances 0.000 description 1
• IIWVFLOQEJCOIX-UHFFFAOYSA-N oxathiaphospholane Chemical compound C1CPSO1 IIWVFLOQEJCOIX-UHFFFAOYSA-N 0.000 description 1
• 229910052760 oxygen Inorganic materials 0.000 description 1
• 239000001301 oxygen Substances 0.000 description 1
• 201000002528 pancreatic cancer Diseases 0.000 description 1
• 230000001717 pathogenic effect Effects 0.000 description 1
• 238000003909 pattern recognition Methods 0.000 description 1
• 239000008188 pellet Substances 0.000 description 1
• 229940049954 penicillin Drugs 0.000 description 1
• 239000012466 permeate Substances 0.000 description 1
• PTMHPRAIXMAOOB-UHFFFAOYSA-L phosphoramidate Chemical compound NP([O-])([O-])=O PTMHPRAIXMAOOB-UHFFFAOYSA-L 0.000 description 1
• 239000000049 pigment Substances 0.000 description 1
• 239000006187 pill Substances 0.000 description 1
• 239000013612 plasmid Substances 0.000 description 1
• 239000004014 plasticizer Substances 0.000 description 1
• 229920002401 polyacrylamide Polymers 0.000 description 1
• 229920001610 polycaprolactone Polymers 0.000 description 1
• 229920006149 polyester-amide block copolymer Polymers 0.000 description 1
• 238000003752 polymerase chain reaction Methods 0.000 description 1
• 108091033319 polynucleotide Proteins 0.000 description 1
• 102000040430 polynucleotide Human genes 0.000 description 1
• 239000002157 polynucleotide Substances 0.000 description 1
• 229920001184 polypeptide Polymers 0.000 description 1
• 229920001282 polysaccharide Polymers 0.000 description 1
• 239000005017 polysaccharide Substances 0.000 description 1
• 150000004804 polysaccharides Chemical class 0.000 description 1
• 239000013641 positive control Substances 0.000 description 1
• 239000011591 potassium Substances 0.000 description 1
• 229910052700 potassium Inorganic materials 0.000 description 1
• OXCMYAYHXIHQOA-UHFFFAOYSA-N potassium;[2-butyl-5-chloro-3-[[4-[2-(1,2,4-triaza-3-azanidacyclopenta-1,4-dien-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol Chemical compound [K+].CCCCC1=NC(Cl)=C(CO)N1CC1=CC=C(C=2C(=CC=CC=2)C2=N[N-]N=N2)C=C1 OXCMYAYHXIHQOA-UHFFFAOYSA-N 0.000 description 1
• 229920001592 potato starch Polymers 0.000 description 1
• 230000002335 preservative effect Effects 0.000 description 1
• 208000025638 primary cutaneous T-cell non-Hodgkin lymphoma Diseases 0.000 description 1
• 238000012545 processing Methods 0.000 description 1
• 239000003380 propellant Substances 0.000 description 1
• 238000012342 propidium iodide staining Methods 0.000 description 1
• MWWATHDPGQKSAR-UHFFFAOYSA-N propyne Chemical compound CC#C MWWATHDPGQKSAR-UHFFFAOYSA-N 0.000 description 1
• 238000011002 quantification Methods 0.000 description 1
• 230000005855 radiation Effects 0.000 description 1
• 206010037833 rales Diseases 0.000 description 1
• 108091008146 restriction endonucleases Proteins 0.000 description 1
• 238000012552 review Methods 0.000 description 1
• 229960000329 ribavirin Drugs 0.000 description 1
• HZCAHMRRMINHDJ-DBRKOABJSA-N ribavirin Natural products O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1N=CN=C1 HZCAHMRRMINHDJ-DBRKOABJSA-N 0.000 description 1
• 125000000548 ribosyl group Chemical group C1([C@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 1
• 229940100486 rice starch Drugs 0.000 description 1
• 235000019515 salmon Nutrition 0.000 description 1
• 230000007017 scission Effects 0.000 description 1
• 230000009291 secondary effect Effects 0.000 description 1
• 230000003248 secreting effect Effects 0.000 description 1
• 238000012163 sequencing technique Methods 0.000 description 1
• 239000008159 sesame oil Substances 0.000 description 1
• 235000011803 sesame oil Nutrition 0.000 description 1
• 231100000004 severe toxicity Toxicity 0.000 description 1
• 238000007493 shaping process Methods 0.000 description 1
• 102000034285 signal transducing proteins Human genes 0.000 description 1
• 108091006024 signal transducing proteins Proteins 0.000 description 1
• 229920000260 silastic Polymers 0.000 description 1
• 201000000849 skin cancer Diseases 0.000 description 1
• 239000002002 slurry Substances 0.000 description 1
• 208000000587 small cell lung carcinoma Diseases 0.000 description 1
• 150000003384 small molecules Chemical class 0.000 description 1
• 239000011734 sodium Substances 0.000 description 1
• 229910052708 sodium Inorganic materials 0.000 description 1
• 235000010413 sodium alginate Nutrition 0.000 description 1
• 239000000661 sodium alginate Substances 0.000 description 1
• 229940005550 sodium alginate Drugs 0.000 description 1
• 239000011775 sodium fluoride Substances 0.000 description 1
• 235000013024 sodium fluoride Nutrition 0.000 description 1
• 239000007901 soft capsule Substances 0.000 description 1
• 239000012439 solid excipient Substances 0.000 description 1
• 238000010532 solid phase synthesis reaction Methods 0.000 description 1
• 230000009870 specific binding Effects 0.000 description 1
• 239000007921 spray Substances 0.000 description 1
• 230000000087 stabilizing effect Effects 0.000 description 1
• 238000010561 standard procedure Methods 0.000 description 1
• 229960005322 streptomycin Drugs 0.000 description 1
• 238000007920 subcutaneous administration Methods 0.000 description 1
• 239000005720 sucrose Substances 0.000 description 1
• 231100000617 superantigen Toxicity 0.000 description 1
• 239000002511 suppository base Substances 0.000 description 1
• 230000001629 suppression Effects 0.000 description 1
• 238000001356 surgical procedure Methods 0.000 description 1
• 239000000375 suspending agent Substances 0.000 description 1
• 238000013268 sustained release Methods 0.000 description 1
• 239000012730 sustained-release form Substances 0.000 description 1
• 239000003765 sweetening agent Substances 0.000 description 1
• 230000008961 swelling Effects 0.000 description 1
• 230000002195 synergetic effect Effects 0.000 description 1
• 230000002194 synthesizing effect Effects 0.000 description 1
• 238000007910 systemic administration Methods 0.000 description 1
• 230000008685 targeting Effects 0.000 description 1
• 201000003120 testicular cancer Diseases 0.000 description 1
• RTKIYNMVFMVABJ-UHFFFAOYSA-L thimerosal Chemical compound [Na+].CC[Hg]SC1=CC=CC=C1C([O-])=O RTKIYNMVFMVABJ-UHFFFAOYSA-L 0.000 description 1
• 229940033663 thimerosal Drugs 0.000 description 1
• 201000002510 thyroid cancer Diseases 0.000 description 1
• 239000004408 titanium dioxide Substances 0.000 description 1
• 230000000699 topical effect Effects 0.000 description 1
• 231100000331 toxic Toxicity 0.000 description 1
• 231100000167 toxic agent Toxicity 0.000 description 1
• 230000002588 toxic effect Effects 0.000 description 1
• 230000009261 transgenic effect Effects 0.000 description 1
• 238000002054 transplantation Methods 0.000 description 1
• 238000011277 treatment modality Methods 0.000 description 1
• QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
• CYRMSUTZVYGINF-UHFFFAOYSA-N trichlorofluoromethane Chemical compound FC(Cl)(Cl)Cl CYRMSUTZVYGINF-UHFFFAOYSA-N 0.000 description 1
• 229940029284 trichlorofluoromethane Drugs 0.000 description 1
• 239000001226 triphosphate Substances 0.000 description 1
• 235000011178 triphosphate Nutrition 0.000 description 1
• 125000002264 triphosphate group Chemical class [H]OP(=O)(O[H])OP(=O)(O[H])OP(=O)(O[H])O* 0.000 description 1
• 210000002993 trophoblast Anatomy 0.000 description 1
• 230000006433 tumor necrosis factor production Effects 0.000 description 1
• 230000014567 type I interferon production Effects 0.000 description 1
• 241000990167 unclassified Simian adenoviruses Species 0.000 description 1
• 241000724775 unclassified viruses Species 0.000 description 1
• 238000011144 upstream manufacturing Methods 0.000 description 1
• 229940035893 uracil Drugs 0.000 description 1
• 201000005112 urinary bladder cancer Diseases 0.000 description 1
• 201000006266 variola major Diseases 0.000 description 1
• 201000000627 variola minor Diseases 0.000 description 1
• 208000014016 variola minor infection Diseases 0.000 description 1
• 239000013598 vector Substances 0.000 description 1
• 239000013603 viral vector Substances 0.000 description 1
• 238000005406 washing Methods 0.000 description 1
• XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
• 239000001993 wax Substances 0.000 description 1
• 238000005303 weighing Methods 0.000 description 1
• 238000001262 western blot Methods 0.000 description 1
• 229940100445 wheat starch Drugs 0.000 description 1